Crown (CCK) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Mar, 2026Executive summary
The 2026 Annual Meeting will be held on April 30, 2026, in Tampa, Florida, with shareholders of record as of March 10, 2026, eligible to vote.
Four proposals are on the agenda: election of directors, ratification of independent auditors, advisory vote on executive compensation, and a shareholder proposal on written consent rights.
The Board recommends voting for all director nominees, for ratification of auditors, for executive compensation, and against the shareholder proposal.
Voting matters and shareholder proposals
Ten director nominees, all current board members, are up for election; nine are independent.
Proposal to ratify PricewaterhouseCoopers LLP as independent auditors for 2026.
Advisory vote on executive compensation (Say-on-Pay) is recommended for approval.
Shareholder proposal to allow action by written consent is opposed by the Board.
Board of directors and corporate governance
Board refreshment added six new independent directors in the last six years, enhancing diversity and skills.
Board practices include annual director elections, mandatory retirement, proxy access, and no poison pill.
All key committees are composed solely of independent directors; robust stock ownership guidelines are in place.
The Board’s Independent Lead Director has broad authority and leads executive sessions.
Latest events from Crown
- Record EBITDA, strong cash flow, and improved leverage drive positive 2026 outlook.CCK
Q4 20255 Feb 2026 - Strong global beverage can growth, higher earnings, and a $2B buyback program announced.CCK
Q2 20243 Feb 2026 - Strong beverage can growth and higher income offset by pension settlement charges.CCK
Q3 202419 Jan 2026 - Record EBITDA, strong cash flow, and reduced leverage highlight a positive 2025 outlook.CCK
Q4 20248 Jan 2026 - Q1 net income up to $193M, adjusted EPS up 64%, and guidance raised on strong can demand.CCK
Q1 20256 Jan 2026 - Board backs director elections, auditor, and pay, but opposes political spending disclosure proposal.CCK
Proxy Filing1 Dec 2025 - Q2 adjusted EPS up 19%, sales and cash flow strong, and guidance raised for the year.CCK
Q2 20254 Nov 2025 - Q3 2025 delivered higher sales, strong European growth, and raised guidance with robust shareholder returns.CCK
Q3 202530 Oct 2025